SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-06-039471
Filing Date
2006-02-27
Accepted
2006-02-27 10:14:31
Documents
1
Group Members
ATLAS GLOBAL INVESTMENTS II, LTDATLAS GLOBAL INVESTMENTS, LTDATLAS GLOBAL, LLCATLAS MASTER FUND, LTDDMITRY BALYASNYVISIUM BALANCED FUND, LPVISIUM BALANCED LONG BIAS FUND, LTDVISIUM BALANCED OFFSHORE FUND, LTD.VISIUM CAPITAL MANAGEMENT, LLCVISIUM LONG BIAS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 301305
  Complete submission text file 0001193125-06-039471.txt   303705
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-46121 | Film No.: 06645163
SIC: 2834 Pharmaceutical Preparations

Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602
Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G